Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease

ClinicalTrials.gov ID: NCT01983449

Public ClinicalTrials.gov record NCT01983449. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 7:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To assess the safety and effectiveness of adventitial deposition of the Study Drug in reducing inflammation and restenosis in patients with clinical evidence of claudication or critical limb ischemia and an angiographically significant lesion in the superficial femoral and/or popliteal arteries. Study Drug and Dose: Dexamethasone Sodium Phosphate Injection, USP, 4 mg/ml, with dilute contrast (17%) administered to the adventitia in a dose of 1.6 mg per cm of desired vessel treatment length.

Study identification

NCT ID
NCT01983449
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Mercator MedSystems, Inc.
Industry
Enrollment
285 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2013 (Type not available)
Primary completion
Dec 2016 (Actual)
Completion
Jan 2018 (Actual)
Last update posted
Mar 8, 2018

2013 – 2018

United States locations

U.S. sites
38
U.S. states
24
U.S. cities
36
Facility City State ZIP Site status
Arizona Heart Hospital / Abrazo Health Care Research / Tenet Health Phoenix Arizona 85016 —
Pima Vascular Tucson Arizona 85718 —
Arkansas Heart Hospital Little Rock Arkansas 72211 —
Cardiovascular Medical Group of Southern California / Cardiovascular Research Foundation Beverly Hills California 90210 —
St. Joseph Hospital of Orange Heart and Vascular Center Orange California 92868 —
San Francisco VA Medical Center San Francisco California 94121 —
University of California San Francisco Medical Center San Francisco California 94131 —
VA Eastern Colorado Healthcare System Denver Colorado 80220 —
Hartford Hospital Hartford Connecticut 06702 —
MedStar Health Washington Hospital Center Washington D.C. District of Columbia 20010 —
First Coast Cardiovascular Institute Jacksonville Florida 32216 —
Munroe Regional Medical Center Ocala Florida 34471 —
Coastal Vascular & Interventional Pensacola Florida 32504 —
St. Joseph Hospital Fort Wayne Indiana 46802 —
Willis-Knighton Medical Center Shreveport Louisiana 71103 —
UMass Medical School Worcester Massachusetts 01655 —
St. John Providence Hospital and Medical Center Detroit Michigan 48326 —
Hattiesburg Clinic Hattiesburg Mississippi 39401 —
University of Mississippi Medical Center Jackson Mississippi 39216 —
St.Louis University Hospital St Louis Missouri 63110 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03766 —
Deborah Heart & Lung Center Browns Mills New Jersey 08015 —
Hunterdon Medical Center Flemington New Jersey 08822 —
Rutgers New Jersey Medical School Newark New Jersey 07103 —
Albany Vascular Group Albany New York 12208 —
Gotham Cardiovascular Research / New York Cardiovascular Associates New York New York 10001 —
Columbia University Medical Center New York New York 10032 —
UNC Health Care - Rex Hospital Raleigh North Carolina 27607 —
OhioHealth Columbus Ohio 43214 —
UPMC Heart & Vascular Institute Pittsburgh Pennsylvania 15232 —
The Miriam Hospital Providence Rhode Island 02906 —
Wellmont CVA Heart Institute Kingsport Tennessee 37660 —
DFW Vascular Group Dallas Texas 75208 —
Plaza Medical Center at Fort Worth Fort Worth Texas 76104 —
Palestine Regional Medical Center Palestine Texas 75801 —
Mission Research Institute (Guadalupe Regional Medical Center) Seguin Texas 78155 —
Alpine Research / Utah Cardiology Salt Lake City Utah 84041 —
University of Washington Veterans Center Seattle Washington 98195 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01983449, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 8, 2018 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01983449 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →